Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California. Show more

4370 La Jolla Village Drive, San Diego, CA, 92122, United States

Biotechnology

Healthcare

Market Cap

130.4M

52 Wk Range

$3.35 - $17.94

Previous Close

$5.96

Open

$5.96

Volume

337,294

Day Range

$5.73 - $6.57

Enterprise Value

39.46M

Cash

91.2M

Avg Qtr Burn

-18.87M

Insider Ownership

16.12%

Institutional Own.

56.23%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ARD-101 Details Prader-Willi Syndrome	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ARD-201 (DPP-4 Combination) Details Obesity	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.